Euglycemic Ketoacidosis Caused by Sodium-Glucose Cotransporter 2 Inhibitors: A Case Report

Ann Intern Med. 2016 Oct 4;165(7):530-532. doi: 10.7326/L15-0535.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood Glucose / metabolism*
  • Canagliflozin / adverse effects*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Ketosis / blood*
  • Ketosis / chemically induced*
  • Liraglutide / therapeutic use
  • Metformin / therapeutic use
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Canagliflozin
  • Liraglutide
  • Metformin